ArticleThe Journal of clinical investigation2016

Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine.

James Nagarajah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.